Hair Thinning? Britannia Life Sciences Launches CBD Trial For Hair Loss Treatment
Hair Thinning? Britannia Life Sciences Launches CBD Trial For Hair Loss Treatment
Britannia Life Sciences Inc. (CSE:BLAB), a global product development platform for cosmetic and wellness products, is launching a consumer trial to test the efficacy of CBD oil as an active ingredient in the treatment of hair loss.
化妆品和健康产品的全球产品开发平台Britannia Life Sciences Inc.(CSE: BLAB)正在启动一项消费者试验,以测试CBD油作为活性成分治疗脱发的功效。
This hair growth initiative is aligned with Britannia's strategy of utilizing its resources and expertise to build a high-value intellectual property portfolio while growing the market for CBD by developing a broad range of new applications across a wide range of products, the company noted in a press statement.
该公司在一份新闻声明中指出,这项生发计划符合不列颠尼亚的战略,即利用其资源和专业知识建立高价值的知识产权组合,同时通过在各种产品中开发广泛的新应用来发展CBD市场。
Britannia has engaged its subsidiary, Advanced Development and Safety Laboratories to finalize the formulation of a topical cream, which utilizes CBD-rich, broad-spectrum hemp oil distillate with the goal of promoting hair growth and density.
Britannia已聘请其子公司高级开发与安全实验室完成外用乳霜的配方,该外用乳霜使用富含CBD的广谱大麻油蒸馏液,旨在促进头发生长和密度。
With sales of over $3 billion in 2020, the global hair loss treatment market is expected to grow at an annual rate of between 4 and 6% through 2027, based on industry estimates.
根据行业估计,2020年的销售额超过30亿美元,预计到2027年,全球脱发治疗市场将以4%至6%的年增长率增长。
The Trial: The consumer trial will be managed by ADSL's existing First Beauty platform and conducted under the guidance and supervision of health professionals.
试验:消费者试验将由ADSL现有的First Beauty平台管理,并在卫生专业人员的指导和监督下进行。
In its initial phase, participants will test a topical cream, providing weekly feedback, over a six-month period.
在初始阶段,参与者将在六个月内测试外用药膏,每周提供反馈。
Photo by Towfiqu barbhuiya on Unsplash
由 Towfiqu barbhuiya 在 Unsplash